Type |
Details |
Score |
Publication |
First Author: |
Nakamura T |
Year: |
1996 |
Journal: |
Oncogene |
Title: |
N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway. |
Volume: |
13 |
Issue: |
6 |
Pages: |
1111-21 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The SH2-containing Shc adapter proteins are targets of activated tyrosine kinases and are implicated in the transmission of activation signals to the Ras/mitogen-activated protein kinase (MAPK) pathway []. Three Shc genes were originally identified in mammals that encode proteins characterised by an amino-terminal phosphotyrosine binding (PTB) domain and a carboxy-terminal Src homology 2 domain. Shc1 (ShcA) is ubiquitously expressed, whereas expression of Shc2 (ShcB) and Shc3 (ShcC) appears to be limited to neuronal cells [].Shc3 (also known as NShc from neuronal Shc) mediates neurotrophin and other neuronal signallings in the central nervous system [, ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Ravichandran KS |
Year: |
2001 |
Journal: |
Oncogene |
Title: |
Signaling via Shc family adapter proteins. |
Volume: |
20 |
Issue: |
44 |
Pages: |
6322-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jones N |
Year: |
2007 |
Journal: |
Mol Cell Biol |
Title: |
Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinase. |
Volume: |
27 |
Issue: |
13 |
Pages: |
4759-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Audero E |
Year: |
2004 |
Journal: |
J Biol Chem |
Title: |
Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells. |
Volume: |
279 |
Issue: |
13 |
Pages: |
13224-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ursini-Siegel J |
Year: |
2012 |
Journal: |
Oncogene |
Title: |
The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival. |
Volume: |
31 |
Issue: |
48 |
Pages: |
5038-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ahn R |
Year: |
2013 |
Journal: |
Cancer Res |
Title: |
The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression. |
Volume: |
73 |
Issue: |
14 |
Pages: |
4521-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Northey JJ |
Year: |
2013 |
Journal: |
J Biol Chem |
Title: |
Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis. |
Volume: |
288 |
Issue: |
7 |
Pages: |
5210-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Turco MY |
Year: |
2012 |
Journal: |
Stem Cells |
Title: |
Cellular heterogeneity during embryonic stem cell differentiation to epiblast stem cells is revealed by the ShcD/RaLP adaptor protein. |
Volume: |
30 |
Issue: |
11 |
Pages: |
2423-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wills MK |
Year: |
2014 |
Journal: |
Mol Biol Cell |
Title: |
The ShcD signaling adaptor facilitates ligand-independent phosphorylation of the EGF receptor. |
Volume: |
25 |
Issue: |
6 |
Pages: |
739-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou MM |
Year: |
1995 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. |
Volume: |
92 |
Issue: |
17 |
Pages: |
7784-8 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
The SH2-containing Shc adapter proteins are targets of activated tyrosine kinases and are implicated in the transmission of activation signals to the Ras/mitogen-activated protein kinase (MAPK) pathway []. Three Shc genes were originally identified in mammals that encode proteins characterised by an amino-terminal phosphotyrosine binding (PTB) domain and a carboxy-terminal Src homology 2 domain. Shc1 (ShcA) is ubiquitously expressed, whereas expression of Shc2 (ShcB) and Shc3 (ShcC) appears to be limited to neuronal cells [].SHC is composed of an N-terminal domain that interacts with proteins containing phosphorylated tyrosines, a (glycine/proline)-rich collagen-homology domain that contains the phosphorylated binding site, and a C-terminal SH2 domain. SH2 has been shown to interact with the tyrosine-phosphorylated receptors of EGF and PDGF and with the tyrosine-phosphorylated C chain of the T-cell receptor, providing one of the mechanisms of T-cell-mediated Ras activation []. In general SH2 domains are involved in signal transduction. They typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites [, , ]. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The SH2-containing Shc adapter proteins are targets of activated tyrosine kinases and are implicated in the transmission of activation signals to the Ras/mitogen-activated protein kinase (MAPK) pathway []. Three Shc genes were originally identified in mammals that encode proteins characterised by an amino-terminal phosphotyrosine binding (PTB) domain and a carboxy-terminal Src homology 2 domain. Shc1 (ShcA) is ubiquitously expressed, whereas expression of Shc2 (ShcB) and Shc3 (ShcC) appears to be limited to neuronal cells [].A fourth Shc family protein, ShcD/Shc4, is expressed in adult brain and skeletal muscle. ShcD can associate via its PTB domain with the phosphorylated muscle-specific kinase (MuSK) receptor tyrosine kinase and undergo tyrosine phosphorylation downstream of activated MuSK. Therefore, ShcD may mediate a specific aspect of signalling downstream of the MuSK receptor []. ShcD also interacts with EGFR receptor (epidermal growth factor receptor) and facilitates its ligand-independent phosphorylation []. ShcD has been shown to be a modulator in the transition of embryonic stem cell (ESC) to epiblast stem cells (EpiSCs), the initial step for ESCs to commit to differentiation []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The SH2-containing Shc adapter proteins are targets of activated tyrosine kinases and are implicated in the transmission of activation signals to the Ras/mitogen-activated protein kinase (MAPK) pathway []. Three Shc genes were originally identified in mammals that encode proteins characterised by an amino-terminal phosphotyrosine binding (PTB) domain and a carboxy-terminal Src homology 2 domain. Shc1 (ShcA) is ubiquitously expressed, whereas expression of Shc2 (ShcB) and Shc3 (ShcC) appears to be limited to neuronal cells [].Shc1 (ShcA) adaptor transduces phosphotyrosine-dependent signals downstream of receptor tyrosine kinases (RTK) and non-RTKs, which regulates signalling pathways in breast cancer cells []. Its SH2 domain is critical for tumour survival during mammary tumorigenesis [], while its PTB domain functions as a biological sensor of phosphotyrosine signalling during breast cancer progression []. Shc1 is required for transforming growth factor beta (TGF-beta)-induced breast cancer cell migration, invasion, and metastasis []. It is also involved in signalling downstream of the angiopoietin receptor TEK/TIE2, and plays a role in the regulation of endothelial cell migration and sprouting angiogenesis []. |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
461
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
474
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
579
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
626
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
573
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
594
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
340
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
262
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
219
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
172
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
118
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
280
 |
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Grucza RA |
Year: |
1999 |
Journal: |
Med Res Rev |
Title: |
SH2 domains: from structure to energetics, a dual approach to the study of structure-function relationships. |
Volume: |
19 |
Issue: |
4 |
Pages: |
273-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kasembeli MM |
Year: |
2009 |
Journal: |
Front Biosci (Landmark Ed) |
Title: |
SH2 domain binding to phosphopeptide ligands: potential for drug targeting. |
Volume: |
14 |
|
Pages: |
1010-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Filippakopoulos P |
Year: |
2009 |
Journal: |
Curr Opin Struct Biol |
Title: |
SH2 domains: modulators of nonreceptor tyrosine kinase activity. |
Volume: |
19 |
Issue: |
6 |
Pages: |
643-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gerhard DS |
Year: |
2004 |
Journal: |
Genome Res |
Title: |
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
Volume: |
14 |
Issue: |
10B |
Pages: |
2121-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huttlin EL |
Year: |
2010 |
Journal: |
Cell |
Title: |
A tissue-specific atlas of mouse protein phosphorylation and expression. |
Volume: |
143 |
Issue: |
7 |
Pages: |
1174-89 |
|
•
•
•
•
•
|